Date of Conferral
Doctor of Business Administration (D.B.A.)
Indian pharmaceutical companies spend one-third of their revenue from supply chain management (SCM) activities due to inherently poor transportation infrastructure. SCM is a vital function for many companies, as it is usually employed to lower expenses and increase sales for the company. SCM costs are higher in India than they are in other areas of the world, amounting to 13% of India's GDP. The purpose of this study was to explore SCM strategies Indian business leaders in the pharmaceutical industry have used to reduce the high costs associated with SCM. This study used a single case study research design and semistructured interviews to collect data from 3 SCM business leaders working in Indian pharmaceutical organizations and possessing successful experience in using SCM strategies to reduce high costs. Goldratt's (1990) theory of constraints was used as the conceptual framework for this study to identify challenges associated with SCM strategies. Data from semistructured interviews, observations, and company documents were processed and analyzed using data source triangulation, grouping the raw data into key themes. The following 3 themes emerged: distribution and logistics challenges, impact of SCM processes, and best practices and solutions. The implications for positive social change include the potential to reduce supply chain risk, which could lead to lower product prices for consumers, increased stakeholder satisfaction, and a higher standard of living.
Bolineni, Prasad, "The Indian Pharmaceutical Industry's Supply Chain Management Strategies" (2016). Walden Dissertations and Doctoral Studies. 2394.